Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

338 Results

Guidelines and Advice

Follow-up for Cervical Cancer

Status: Current
ID: 4-16
Version: 3

May 2025

Guidelines and Advice

Effective Teaching Strategies and Methods for Cancer Patient Education

Status: Current
ID: GL 20-2
Version: 2

Apr 2025

Guidelines and Advice

Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer

Status: Archived
ID: 3-1

Nov 2011

Guidelines and Advice

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Status: Archived
ID: 3-12

Nov 2011

Guidelines and Advice

Surveillance Programs for Early Stage Nonseminomatous Testicular Cancer

Status: Archived
ID: 3-5

Nov 2011

Guidelines and Advice

Use of Strontium 89 in Patients with Endocrine-Refractory Carcinoma of the Prostate Metastatic to Bone

Status: Archived
ID: 3-6

Nov 2011

Guidelines and Advice

Fecal Immunochemical Tests Compared With Guaiac Fecal Occult Blood Tests for Population-Based Colorectal Cancer Screening

Status: Archived
ID: 15-8

Nov 2011

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Mar 2025

Guidelines and Advice

Bone Health and Bone-Targeted Therapies for Prostate Cancer

Status: Current
ID: 3-14
Version: 3

Updated

Jun 2025

Guidelines and Advice

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Status: Current
ID: GL 17-10 v2
Version: 2

Mar 2025

Guidelines and Advice

Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer

Status: Current
ID: GL MOTAC-4
Version: 3

Updated

Jun 2025

Guidelines and Advice

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Nov 2011

Pages